Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-026895·Trails Edge Capital Partners, LP
Schedule 13G ownership disclosure
VTV THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 918385204
Event date: 2025-08-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Trails Edge Capital Partners, LP
Shares: 340,536.00 · Class: 9.9%
- Trails Edge Biotechnology Master Fund, LP
Shares: 340,536.00 · Class: 9.9%
- Ortav Yehudai
Shares: 340,536.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-026895
- Form type
- SCHEDULE 13G
- Filer
- Trails Edge Capital Partners, LP
- CIK
- CIK 2077247
- Filed
- Sep 08, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership